Cytokinetics, Inc. Announces Scientific Poster to be Presented at the 47th Annual American Society for Cell Biology Meeting

SOUTH SAN FRANCISCO, CA--(Marketwire - November 26, 2007) - Highlighted Links CYTK Website Cytokinetics, Inc. (NASDAQ: CYTK) announced today that a poster relating to CK-1827452, a novel small molecule activator of cardiac myosin, will be presented at the 47th Annual American Society of Cell Biology (ASCB) meeting at the Washington Convention Center (Halls A-B) in Washington, DC to be held December 1-5, 2007. CK-1827452 is being evaluated in clinical trials for the potential treatment of heart failure and is the subject of a Collaboration and Option Agreement between Cytokinetics and Amgen Inc. Details regarding the scientific presentation are provided below: